PATENT CLAIM ANALYSIS

Application Number: 15980339
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-10
Patent Classification: ["514", "017800"]

Abstract:
The present invention relates to the field of molecular biochemistry and medicine, and in particular to ligands comprising modified amino acid residues, targeting the amyloid-β peptide associated with Alzheimer's disease for prevention of aggregation, neurotoxicity and use thereof as drugs for treatment of Alzheimer's disease.

Claim (Index 24):
The compound according to  claim 1 , said compound being able to decrease the loss of an \u03b1-helix in an A\u03b2 peptide.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.30769
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15326320', '14231715', '15049126', '14231724', '13447127']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7635289714446923
- 35 USC 102 Novelty (BERT): 0.5270373834617792
- Combined Prediction Score: 0.739879812646401
- Mean Citation Score: 287.711694
- Max Citation Score: 296.7792
- Similarity Product: 188.51010398225785

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test